Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · Kernicterus Spectrum Disorder

Diagnosing KSD: Understanding MRI and ABR Reports

At a Glance

Diagnosing Kernicterus Spectrum Disorder (KSD) relies on specific MRI findings, such as T2 hyperintensity in the globus pallidus, and specialized hearing tests. Because standard newborn hearing screens can miss KSD nerve damage, an Auditory Brainstem Response (ABR) test is required.

Diagnosing Kernicterus Spectrum Disorder (KSD) can be a complex process because the signs often change as a child grows. Many families find that their child’s brain imaging or hearing tests initially appeared “normal” or “inconclusive” in the first weeks of life, only for clear patterns to emerge months later [1][2]. Understanding how to read these reports can help you advocate for the right interventions.

Decoding the MRI Report

Magnetic Resonance Imaging (MRI) is a powerful tool for seeing the physical “scarring” left by bilirubin. However, the timing of the scan matters significantly.

  • The Transition: In the first few days (the acute phase), doctors look for bright spots on T1-weighted imaging. As the injury becomes chronic (KSD), these spots usually fade on T1 and instead appear as bright “hyperintensities” on T2-weighted imaging [2][3].
  • The “Blind Window”: There is often a period during early infancy (roughly 1 to 3 months of age) where the brain is reorganizing and MRI findings may temporarily look normal, even if an injury occurred [2].
  • The Classic Sign: In KSD, the most common finding is bilateral symmetric T2 hyperintensity in the globus pallidus [2][4]. This means both sides of the brain’s movement control center show similar scarring. If your report mentions “limited findings restricted to the borders of the globus pallidus,” this is also a known pattern in chronic cases [2].

Why Standard Hearing Screens May Miss KSD

Many children with KSD pass their first newborn hearing screen, which can be confusing for parents. This happens because most basic screens use Otoacoustic Emissions (OAE) [5].

  • OAE vs. ABR: The OAE test only checks if the inner ear (cochlea) is working. In KSD, the inner ear is often perfectly healthy, which is why the child “passes” [5][6].
  • The ABR Difference: To diagnose Auditory Neuropathy Spectrum Disorder (ANSD), doctors must use Auditory Brainstem Response (ABR) testing. This test measures how the nerve actually carries sound to the brain [7][8].
  • What to Look For: A classic ANSD report will show a “cochlear microphonic” (the ear is working) but “absent or poorly differentiated waveforms” (the signal to the brain is scrambled) [9][10].

Clinical Scoring Tools

Because MRI is not always a perfect predictor, doctors use standardized clinical scores to confirm a diagnosis and monitor progression over the first year of life [11].

  • BIND Score (Bilirubin-Induced Neurological Dysfunction): This score is used in the hospital during the acute phase to assess immediate neurological status [12][13]. A modified version, sometimes called the BIND-M (Modified), is used later to score chronic severity.
  • BAD (Barry-Albright Dystonia) Scale: This tool is used to measure the severity of involuntary muscle movements (dystonia) in different parts of the body. It helps doctors quantify the physical impact of the injury and track whether therapies are helping over time [11].

By reviewing these specific terms in your child’s medical records, you can better understand the “map” of their injury and ensure their care team is targeting the right areas for therapy and support.

Common questions in this guide

Why did my child's early MRI look normal if they have KSD?
There is often a 'blind window' between 1 to 3 months of age where the brain is reorganizing. During this time, MRI findings may temporarily appear normal even if a bilirubin injury occurred.
What does T2 hyperintensity in the globus pallidus mean on an MRI?
T2 hyperintensity indicates physical scarring left by bilirubin. In KSD, it is most commonly seen as a bright spot in the globus pallidus, which is the movement control center of the brain.
Why did my child pass the newborn hearing screen but still have hearing issues?
Basic newborn screens use OAE testing, which only checks the inner ear. KSD affects the nerve that carries sound to the brain, leaving the inner ear healthy but disrupting the signal. An ABR test is needed to detect this type of hearing loss.
How does Auditory Neuropathy Spectrum Disorder (ANSD) show up on an ABR test?
An ABR report for ANSD typically shows that the ear is working properly, but the nerve signals to the brain are absent or poorly differentiated. This means the sound signal gets scrambled before it reaches the brain.
What is the BIND score used for in KSD?
The BIND (Bilirubin-Induced Neurological Dysfunction) score assesses an infant's neurological status after a bilirubin injury. A modified version is often used later to score the chronic severity of the condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my child's MRI performed during the 'blind window' when findings are often hard to see, and should it be repeated now that they are older?
  2. 2.Can you show me the specific areas of high signal intensity (hyperintensity) in the globus pallidus on the T2-weighted images?
  3. 3.What were the results of the BAD score for my child at our last evaluation?
  4. 4.My child passed the OAE screen as a newborn; does this report show the presence of a 'cochlear microphonic,' and what does that mean for their hearing?
  5. 5.How does the 'neural dys-synchrony' noted in the ABR report specifically affect how my child processes speech?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Neonatal hyperbilirubinemia and bilirubin neurotoxicity: what can be learned from the database analysis?

    Cornet MC, Kemper AR, Maisels MJ, et al.

    Pediatric research 2022; (92(5)):1204 doi:10.1038/s41390-022-01973-5.

    PMID: 35136201
  2. 2

    Acute and Chronic Kernicterus: MR Imaging Evolution of Globus Pallidus Signal Change during Childhood.

    Gburek-Augustat J, Sorge I, Stange M, et al.

    AJNR. American journal of neuroradiology 2023; (44(9)):1090-1095 doi:10.3174/ajnr.A7948.

    PMID: 37620154
  3. 3

    Diagnostic value of conventional MRI combined with DTI for neonatal hyperbilirubinemia.

    Yan R, Han D, Ren J, et al.

    Pediatrics and neonatology 2018; (59(2)):161-167 doi:10.1016/j.pedneo.2017.07.009.

    PMID: 28864243
  4. 4

    MRI of bilirubin encephalopathy (kernicterus): A case series of 4 patients from Sub-Saharan Africa, May 2017.

    Assefa Neknek G, Woldemichael K, Moges A, Zewdneh Solomon D

    Radiology case reports 2018; (13(3)):676-679 doi:10.1016/j.radcr.2018.03.018.

    PMID: 30046365
  5. 5

    Duration of Cochlear Microphonics in Click and Toneburst-Evoked Auditory Brainstem Response in Individuals With Auditory Neuropathy Spectrum Disorder and Normal Hearing.

    Sasidharan M, Gore M, Mathew A, Praisy M

    Cureus 2023; (15(10)):e46734 doi:10.7759/cureus.46734.

    PMID: 38022153
  6. 6

    Identification of a novel pathogenic OTOF variant causative of nonsyndromic hearing loss with high frequency in the Ashkenazi Jewish population.

    Fedick AM, Jalas C, Swaroop A, et al.

    The application of clinical genetics 2016; (9()):141-6 doi:10.2147/TACG.S113828.

    PMID: 27621663
  7. 7

    Auditory brainstem response in preterm infants with bilirubin encephalopathy.

    Okumura A, Kitai Y, Arai H, et al.

    Early human development 2021; (154()):105319 doi:10.1016/j.earlhumdev.2021.105319.

    PMID: 33530022
  8. 8

    Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.

    Kemper AR, Newman TB, Slaughter JL, et al.

    Pediatrics 2022; (150(3)) doi:10.1542/peds.2022-058859.

    PMID: 35927462
  9. 9

    Study of cochlear microphonic potentials in auditory neuropathy.

    Soares ID, Menezes PL, Carnaúba AT, et al.

    Brazilian journal of otorhinolaryngology 2016; (82(6)):722-736 doi:10.1016/j.bjorl.2015.11.022.

    PMID: 27177976
  10. 10

    Acquired auditory neuropathy spectrum disorder after malaria treated with quinine.

    Brough H

    Tropical doctor 2020; (50(3)):246-248 doi:10.1177/0049475520917236.

    PMID: 32290759
  11. 11

    Predictive and diagnostic measures for kernicterus spectrum disorder: a prospective cohort study.

    Gelineau-Morel R, Usman F, Shehu S, et al.

    Pediatric research 2024; (95(1)):285-292 doi:10.1038/s41390-023-02810-z.

    PMID: 37689774
  12. 12

    Prediction of 3- to 5-Month Outcomes from Signs of Acute Bilirubin Toxicity in Newborn Infants.

    El Houchi SZ, Iskander I, Gamaleldin R, et al.

    The Journal of pediatrics 2017; (183()):51-55.e1 doi:10.1016/j.jpeds.2016.12.079.

    PMID: 28131490
  13. 13

    Characteristics and outcome of newborn admitted with acute bilirubin encephalopathy to a tertiary neonatal intensive care unit.

    Helal NF, Ghany EAGA, Abuelhamd WA, Alradem AYA

    World journal of pediatrics : WJP 2019; (15(1)):42-48 doi:10.1007/s12519-018-0200-4.

    PMID: 30406356

This page explains KSD diagnostic terminology for educational purposes only. Your child's neurologist and audiologist are the best sources for interpreting their specific MRI and ABR reports.

Get notified when new evidence is published on Chronic bilirubin encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.